chr12-77025593-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_203394.3(E2F7):c.2530G>A(p.Val844Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,614,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_203394.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
E2F7 | NM_203394.3 | c.2530G>A | p.Val844Met | missense_variant | 12/13 | ENST00000322886.12 | NP_976328.2 | |
E2F7 | XM_011537966.3 | c.2395G>A | p.Val799Met | missense_variant | 11/12 | XP_011536268.1 | ||
E2F7 | XM_011537969.3 | c.2227G>A | p.Val743Met | missense_variant | 11/12 | XP_011536271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
E2F7 | ENST00000322886.12 | c.2530G>A | p.Val844Met | missense_variant | 12/13 | 1 | NM_203394.3 | ENSP00000323246 | P1 | |
E2F7 | ENST00000416496.6 | c.2141-1408G>A | intron_variant | 5 | ENSP00000393639 |
Frequencies
GnomAD3 genomes AF: 0.000539 AC: 82AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251406Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135874
GnomAD4 exome AF: 0.000121 AC: 177AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.000106 AC XY: 77AN XY: 727248
GnomAD4 genome AF: 0.000538 AC: 82AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000483 AC XY: 36AN XY: 74466
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 31, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at